Follow us
Contact        Jobs        Newsletter        Devenir membre

Plasmid DNA and Advanced Therapies: Accelerating Path to Clinic

Webinar in collaboration with BioWin

Date: December 8, 2022
Time: 14:00 CET/ 13:00 GMT/ 08:00 EST

Webinar in collaboration with BioWin

Register for the webinar


Gene therapies and emerging biomodalities are developing at an unprecedent pace, improving the lives of patients around the world. The high demand for those treatments opens a competitive market in which faster and high-quality cost-effective solutions are a clear advantage. The starting point for advanced therapies is generally DNA in the shape of plasmid DNA (pDNA). GMP requirements from early stage, together with the right tools and analytics providing the highest quality standards for pDNA, will ensure successful downstream applications as AAV, from early clinical development to commercial phase.

Join this webinar for an in-depth discussion of the challenges CGT innovators face and how experts resolve these barriers through adopting technology and strategy that drive an optimized plasmid production process and supply.

Key learning objectives

1.   Learn the current plasmid DNA manufacturing landscape.

2.   Discuss key considerations during plasmid production, including design and screening system and processing.

3.   Discuss main challenges linked to GMP pDNA production and the impact on different advanced therapy programs.


·       Nuria Gomez Santos, Ph.D,

Head of Process & Analytical Development, pDNA

·       Prof Eli Keshavarz-Moore, Professor of Bioprocess Science & Enterprise, Dept of Biochemical Engineering, Faculty of Engineering Science, UCL


 Thierry Ferain, Director Innovation & Growth, BioWin

Register Now 

Date et heure
jeudi décembre 08, 2022
14:00 16:00 (Europe/Brussels)

Zoom Webinar

--Zoom Webinar--
--Zoom Webinar--
Obtenez l'itinéraire


+44 7825 015559

Découvrez ce que les gens voient et disent à propos de cet événement et rejoignez la conversation.

Les inscriptions sont fermées